Walker S McKinney, Lauren M Schmitt, Jennifer R Ruberg, Marika Coffman, Debra Reisinger, Rebecca C Shaffer
{"title":"Families' Neighborhood Resources Predict Treatment Response for Regulating Together, a Group Therapy for Emotion Dysregulation in Autistic Youth.","authors":"Walker S McKinney, Lauren M Schmitt, Jennifer R Ruberg, Marika Coffman, Debra Reisinger, Rebecca C Shaffer","doi":"10.1177/10445463261477348","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Autistic youth often face difficulties with emotion dysregulation (ED) and associated challenging behaviors. The <i>Regulating Together</i> (RT) group therapy was developed to treat ED in autistic youth ages 8-18 years and has been shown to be feasible, acceptable, and efficacious at reducing ED. Results from other clinical trials suggest the efficacy of behavioral therapies may vary based on family- or neighborhood-level social determinants of health (SDOH: \"the conditions in the environments where people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks\"; U.S. Department of Health and Human Services). The extent to which these factors modify treatment response for RT is not known. This knowledge may help identify characteristics of treatment responders, inform implementation strategies to maximize real-world effectiveness, and guide decisions around treatment assignment and dosing.</p><p><strong>Methods: </strong>This is an exploratory, secondary analysis of our previously reported in-person (<i>N</i> = 37) and telehealth (<i>N</i> = 26) nonrandomized trials of RT. Participants included 63 autistic youth (79.3% male; mean age = 12.8 years, SD = 2.9, range = 8-18) and caregivers. ED and related constructs (e.g., cognitive inflexibility) were assessed at baseline, post-treatment, and 5- and 10-week follow-up visits. Neighborhood-level SDOH were indexed using the Child Opportunity Index based on participants' home addresses. Linear mixed-effects models tested whether neighborhood opportunity moderated treatment response.</p><p><strong>Results: </strong>Neighborhood opportunity was unrelated to baseline clinical characteristics. However, neighborhood opportunity moderated treatment outcomes: reductions in irritability and emotional reactivity were greatest among families in neighborhoods with fewer opportunities.</p><p><strong>Discussion: </strong>Our finding of an amplified treatment response among families living in neighborhoods with fewer resources aligns with results from clinical trials for disruptive behaviors and internalizing disorders in typically developing youth. Possible explanations for this include families' limited prior access to behavioral health services, secondary reductions in caregiver stress, or high satisfaction with RT. These results challenge assumptions about diminished efficacy in low-resource settings and underscore the importance of considering contextual factors in future trials to enhance real-world impact.</p>","PeriodicalId":15277,"journal":{"name":"Journal of child and adolescent psychopharmacology","volume":" ","pages":"649-660"},"PeriodicalIF":1.8000,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of child and adolescent psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10445463261477348","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Autistic youth often face difficulties with emotion dysregulation (ED) and associated challenging behaviors. The Regulating Together (RT) group therapy was developed to treat ED in autistic youth ages 8-18 years and has been shown to be feasible, acceptable, and efficacious at reducing ED. Results from other clinical trials suggest the efficacy of behavioral therapies may vary based on family- or neighborhood-level social determinants of health (SDOH: "the conditions in the environments where people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks"; U.S. Department of Health and Human Services). The extent to which these factors modify treatment response for RT is not known. This knowledge may help identify characteristics of treatment responders, inform implementation strategies to maximize real-world effectiveness, and guide decisions around treatment assignment and dosing.
Methods: This is an exploratory, secondary analysis of our previously reported in-person (N = 37) and telehealth (N = 26) nonrandomized trials of RT. Participants included 63 autistic youth (79.3% male; mean age = 12.8 years, SD = 2.9, range = 8-18) and caregivers. ED and related constructs (e.g., cognitive inflexibility) were assessed at baseline, post-treatment, and 5- and 10-week follow-up visits. Neighborhood-level SDOH were indexed using the Child Opportunity Index based on participants' home addresses. Linear mixed-effects models tested whether neighborhood opportunity moderated treatment response.
Results: Neighborhood opportunity was unrelated to baseline clinical characteristics. However, neighborhood opportunity moderated treatment outcomes: reductions in irritability and emotional reactivity were greatest among families in neighborhoods with fewer opportunities.
Discussion: Our finding of an amplified treatment response among families living in neighborhoods with fewer resources aligns with results from clinical trials for disruptive behaviors and internalizing disorders in typically developing youth. Possible explanations for this include families' limited prior access to behavioral health services, secondary reductions in caregiver stress, or high satisfaction with RT. These results challenge assumptions about diminished efficacy in low-resource settings and underscore the importance of considering contextual factors in future trials to enhance real-world impact.
期刊介绍:
Journal of Child and Adolescent Psychopharmacology (JCAP) is the premier peer-reviewed journal covering the clinical aspects of treating this patient population with psychotropic medications including side effects and interactions, standard doses, and research on new and existing medications. The Journal includes information on related areas of medical sciences such as advances in developmental pharmacokinetics, developmental neuroscience, metabolism, nutrition, molecular genetics, and more.
Journal of Child and Adolescent Psychopharmacology coverage includes:
New drugs and treatment strategies including the use of psycho-stimulants, selective serotonin reuptake inhibitors, mood stabilizers, and atypical antipsychotics
New developments in the diagnosis and treatment of ADHD, anxiety disorders, schizophrenia, autism spectrum disorders, bipolar disorder, eating disorders, along with other disorders
Reports of common and rare Treatment Emergent Adverse Events (TEAEs) including: hyperprolactinemia, galactorrhea, weight gain/loss, metabolic syndrome, dyslipidemia, switching phenomena, sudden death, and the potential increase of suicide. Outcomes research.